You have 9 free searches left this month | for more free features.

Splenomegaly

Showing 1 - 25 of 707

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PREDIGA 2: Spanish Acronym of "Educational and Diagnostic

Not yet recruiting
  • Gaucher Disease
  • +4 more
  • Patient with splenomegaly or splenectomy
  • Barcelona, Spain
    Hospital Vall d'Hebron
Dec 13, 2022

Splenomegaly; Congestive, Chronic, Panhematopenia; Splenic, Portal Hypertension Trial in Stockholm (Microwave ablation)

Recruiting
  • Splenomegaly; Congestive, Chronic
  • +2 more
  • Microwave ablation
  • Stockholm, Sweden
    Karolinska University Hospital
Dec 30, 2021

BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of

Recruiting
  • BCR-JAK2 Fusion Protein Expression
  • +11 more
  • Palo Alto, California
  • +3 more
Oct 5, 2022

Pediatric Patients With Unexplained Enlarged Spleen

Recruiting
  • Gaucher Disease, Splenomegaly
  • Acid SphingoMyelinase Deficiency
    • Amiens, France
    • +39 more
    Aug 19, 2022

    DF-003 in ex Vivo Assays Using Peripheral Blood Mononuclear Cell

    Recruiting
    • Unrecognized Condition
    • Adult subjects with ROSAH syndrome
    • Lyon, Rhône-Alpes, France
      Hôpital Nord Croix Rousse
    Sep 9, 2022

    Cholecystitis, Perforated Duodenal Ulcer, Diaphragmatic Hernia Trial in Rawalpindi (Volume-oriented incentive spirometry,

    Completed
    • Cholecystitis
    • +8 more
    • Volume-oriented incentive spirometry
    • Flow-oriented incentive spirometry
    • Rawalpindi, Punjab, Pakistan
      Railway General hospital
    Oct 19, 2021

    Liver Cirrhosis, Esophageal and Gastric Varices, Hypersplenism Trial in Jinan (Endoscopic therapy+ beta blockers, Endoscopic

    Enrolling by invitation
    • Liver Cirrhosis
    • +2 more
    • Endoscopic therapy+ beta blockers
    • +5 more
    • Jinan, Shandong, China
      Qilu Hospital , Shandong University
    Feb 14, 2022

    Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 1

    Active, not recruiting
    • Ann Arbor Stage II Grade 1 Follicular Lymphoma
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 18, 2022

    Biomarker for Farber Disease (BioFarber)

    Active, not recruiting
    • Farber's Lipogranulomatosis
    • +3 more
      • Cairo, Egypt
      • +2 more
      May 17, 2021

      Biomarker for Sly Disease (MPS VII) (BioSly)

      Active, not recruiting
      • Developmental Delay
      • +3 more
        • Cairo, Egypt
        • +4 more
        May 12, 2021

        Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)

        Active, not recruiting
        • Hepato-splenomegaly
        • +3 more
          • Cairo, Egypt
          • +4 more
          May 12, 2021

          Biomarker for Pompe Disease (BioPompe)

          Active, not recruiting
          • Cardiac Diseases
          • +6 more
            • Rostock, Germany
            • +3 more
            May 12, 2021

            Point-of-Care Ultrasound in Diagnosis of Acute Infectious

            Terminated
            • Infectious Mononucleosis
            • Splenomegaly
            • Point-of-care ultrasound
            • Montreal, Quebec, Canada
            • +1 more
            Oct 4, 2020

            Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)

            Terminated
            • Leukemia
            • +3 more
            • Houston, Texas
              University of Texas MD Anderson Cancer Center
            Aug 5, 2020

            Acid Sphingomyelinase Deficiency Disease and Gaucher Disease in

            Recruiting
            • Gaucher Disease
            • Acid SphingoMyelinase Deficiency
              • Ponferrada, León, Spain
              • +11 more
              Aug 8, 2023

              Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)

              Not yet recruiting
              • Metastatic Pancreatic Cancer
              • nanoliposomal irinotecan
              • spleen irradiation
              • (no location specified)
              May 8, 2022

              Chronic Portal Vein Thrombosis in Children

              Not yet recruiting
              • Portal Vein Thrombosis
              • endoscopy
              • (no location specified)
              Nov 3, 2023

              Spleen; Fibrosis Trial in Rotterdam, Cluj-Napoca, Madrid (FibroScan examination (S), FibroScan examination (M), FibroScan

              Recruiting
              • Spleen; Fibrosis
              • FibroScan examination (S)
              • +3 more
              • Rotterdam, Netherlands
              • +3 more
              Aug 5, 2022

              Congenital Cytomegalovirus Infection Trial in Nancy

              Completed
              • Congenital Cytomegalovirus Infection
                • Nancy, France
                  Maternity Hospital CHRU
                Feb 22, 2023

                Hepatomegaly, Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis

                Terminated
                • Hepatomegaly
                • +4 more
                • Laboratory Biomarker Analysis
                • +2 more
                • Houston, Texas
                  M D Anderson Cancer Center
                Apr 23, 2019

                Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

                Recruiting
                • Polycythemia Vera
                • Tianjin, China
                  Institute of Hematology & Blood Diseases Hospital
                May 19, 2023

                Hepatic Cirrhosis, Portal Hypertension Trial in Jinan (Endoscopic therapy+ beta blockers, Endoscopic therapy+ PSE+beta blockers,

                Completed
                • Hepatic Cirrhosis
                • Portal Hypertension
                • Endoscopic therapy+ beta blockers
                • +6 more
                • Jinan, Shandong, China
                  Department of Gastroenterology,Qilu Hospital,Shandong University
                Sep 8, 2021

                Myelofibrosis Trial in France (Clonal architecture determination)

                Not yet recruiting
                • Myelofibrosis
                • Clonal architecture determination
                • Angers, France
                • +6 more
                Jan 24, 2023

                Clinical Evident Portal Hypertension on HCC With TACE

                Not yet recruiting
                • Hepatocellular Carcinoma
                • Portal Hypertension
                • TACE ± Systemic therapy
                • Nanjing, China
                • +1 more
                Jan 19, 2023

                Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

                Recruiting
                • Myeloproliferative Neoplasm
                • +3 more
                • CALR allele burden quantification
                • Angers, France
                  CHU Angers
                Nov 2, 2022